Agilent Technologies (NYSE:A) Given New $142.00 Price Target at Robert W. Baird

Key Points

• Robert W. Baird has increased Agilent Technologies' target price from $141.00 to $142.00, suggesting a potential upside of 15.11% from the company's previous close, while maintaining an "outperform" rating.
• Agilent's stock price rose by 3.9% to reach $123.36 during trading hours, with an average target price among analysts set at $139.25.
• The company reported $1.37 earnings per share for the latest quarter, meeting expectations, with revenue growing by 10.1% compared to the previous year, and has set fiscal year 2025 guidance at $5.560-5.590 EPS.

Agilent Technologies (NYSE:A - Get Free Report) had its target price boosted by equities research analysts at Robert W. Baird from $141.00 to $142.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has an "outperform" rating on the medical research company's stock. Robert W. Baird's price objective would indicate a potential upside of 15.11% from the company's previous close.

Several other brokerages have also weighed in on A. UBS Group dropped their target price on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research report on Thursday, May 29th. TD Cowen upped their target price on Agilent Technologies to $150.00 and gave the stock a "buy" rating in a research report on Thursday, May 29th. Leerink Partners upped their target price on Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research report on Friday, May 30th. JPMorgan Chase & Co. dropped their target price on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a research report on Thursday, May 29th. Finally, Wells Fargo & Company upped their target price on Agilent Technologies from $135.00 to $140.00 and gave the stock an "overweight" rating in a research report on Thursday. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, Agilent Technologies has an average rating of "Moderate Buy" and an average target price of $139.25.

Agilent Technologies Stock Up 3.9%

NYSE:A traded up $4.67 during trading hours on Thursday, hitting $123.36. 1,107,534 shares of the company's stock traded hands, compared to its average volume of 1,935,916. The firm has a market cap of $35.04 billion, a P/E ratio of 30.44, a P/E/G ratio of 3.59 and a beta of 1.22. Agilent Technologies has a twelve month low of $96.43 and a twelve month high of $153.84. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.60 and a current ratio of 2.09. The stock's fifty day moving average price is $117.99 and its two-hundred day moving average price is $116.89.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%.The firm had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the firm earned $1.32 earnings per share. Agilent Technologies's quarterly revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, research analysts expect that Agilent Technologies will post 5.58 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,508 shares of the company's stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the sale, the chief executive officer owned 37,448 shares in the company, valued at approximately $4,397,893.12. This represents a 3.87% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Institutional Trading of Agilent Technologies

Hedge funds have recently added to or reduced their stakes in the business. Sunbelt Securities Inc. boosted its stake in Agilent Technologies by 640.0% during the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock valued at $30,000 after purchasing an additional 192 shares during the period. Whipplewood Advisors LLC lifted its position in shares of Agilent Technologies by 286.2% in the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock worth $29,000 after acquiring an additional 186 shares during the period. Wood Tarver Financial Group LLC bought a new stake in shares of Agilent Technologies in the 4th quarter worth approximately $34,000. Stone House Investment Management LLC bought a new stake in shares of Agilent Technologies in the 1st quarter worth approximately $30,000. Finally, Opal Wealth Advisors LLC bought a new stake in shares of Agilent Technologies in the 1st quarter worth approximately $31,000.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.